TIGIT and PD-L1 co-blockade promotes clonal expansion of multipotent, non-exhausted anti-tumor T cells by facilitating costimulation
Sensitive bispecific chimeric T cell receptors for cancer therapy
Evolutionary trajectories of IDH-mutant astrocytoma identify molecular grading markers related to cell cycling
Identification and targeting of treatment resistant progenitor populations in T-cell Acute Lymphoblastic Leukemia
Prediction of cancer treatment response from histopathology images through imputed transcriptomics
Multiomics analysis reveals a Type III driven immune response in immunotherapy-induced toxicity in melanoma and identifies potential new therapeutic targets
Immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinoma
Robust prediction of patient outcomes with immune checkpoint blockade therapy for cancer using common clinical, pathologic, and genomic features
Acquired resistance to bispecific antibodies by genetic or epigenetic inactivation of the target in multiple myeloma
Evolutionary and immune microenvironment dynamics during neoadjuvant treatment of oesophagael adenocarcinoma